Corporates

Explore the rapidly evolving world of clear aligners and their integration into digital dental workflows. Learn about top dental companies, workflow compatibility, and the benefits of seamless integration for dentists and patients.

Discover the highlights of ASGCT Annual Meeting 2023, featuring breakthroughs in biotechnology, novel approaches, and innovative technologies in the CGT space. Stay updated on the latest advancements and industry trends.

POV on Clear Aligners: Current & Future Trends Get My Publication Overview Traditionally, orthodontists used to treat malocclusion cases among kids,

Discover the key factors in choosing a hearing aid, from severity of hearing loss to warranty and trial periods. Explore the latest technological advancements and growing demand for OTC products.

With the consistent success of cell and gene therapies (CGTs), bioprocessing and the manufacturing facilities have taken centre-stage to meet global demands.

Digital technology, such as AI, big data analytics, wearables, and robotics, has revolutionized healthcare in the past decade with surgical robotics, improving accessibility, efficiency, and equity.

In the rapidly evolving field of ophthalmic surgery, staying at the forefront of technological advancements and understanding the competitive landscape is crucial for success. With increasing demands for better patient outcomes and cost-effective solutions, market players are constantly striving to innovate and outperform their competitors. Our medtech team has expertly curated a comprehensive analysis, delving into the strategic perspectives of key competitors, emerging trends, and future outlook across four essential pillars shaping the ophthalmology landscape.

Almost 80-85% of the post-menopausal women population in the world suffer from vasomotor symptoms (VMS) such as hot flashes, night sweats and other associated symptoms. However, due to the stigma and misinformation associated with women’s health and especially menopause, it still remains an area that is understudied in research, often misunderstood by healthcare providers and patients, and unaddressed by most healthcare policies.

As a central driving force for precision medicine worldwide, the Personalized Medicine Coalition (PMC) noted that more than 220 FDA-approved therapies with a biomarker mentioned in the label as ‘essential’ or ‘recommended for prescribing’ were available in the US market between 2015 and 2021. Further fuelling the movement of value-based care, a drug-diagnostic co-development model has been significantly prevalent, leading to a consistently growing usage of companion diagnostics assays – to target patients expected to benefit most from targeted therapy. As of 2022, 40+ commercialized CDx assays were listed exhaustively in the FDA’s List of Cleared or Approved Companion Diagnostic Devices.